Jennifer L. Hsu

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

38h-index11.5kcitations191works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(40), CAR-T cell therapy research(35), RNA modifications and cancer(32), Epigenetics and DNA Methylation(26), Immunotherapy and Immune Responses(26)

Publications190 total

Cerebrovascular Accident Caused by Coccidioides immitis Basilar Meningitis in a Patient with Stroke Risk Factors.
PubMed·2023
PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
Journal for ImmunoTherapy of Cancer·2023· 11 citedOpen Access
<i>Cymric</i>, a Maternal and Zygotic <i>HTK-16-Like</i> SHARK Family Tyrosine Kinase Gene, Is Disrupted in <i>Molgula occulta</i>, a Tailless Ascidian
Biological Bulletin·2023Open Access
Data from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Methods from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure Legends 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figures 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure Legends 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figures 1-4 from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Data from Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
2023Open Access
Supplementary Figure 6 from Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells
2023Open Access
Data from A novel hTERT promoter–driven E1A therapeutic for ovarian cancer
2023Open Access
Supplementary Data from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
2023Open Access
Data from Oncogenic Functions of Gli1 in Pancreatic Adenocarcinoma Are Supported by Its PRMT1-Mediated Methylation
2023Open Access
Supplementary Table S2 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
2023Open Access
Supplementary Table S3 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
2023Open Access
Figure S2 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
2023Open Access
Supplementary Figure 6 from Caspase-Independent Cell Death Is Involved in the Negative Effect of EGF Receptor Inhibitors on Cisplatin in Non–Small Cell Lung Cancer Cells
2023Open Access
Figure S7 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Mien‐Chie Hung(42), Weiya Xia(24), Jung-Mao Hsu(18), Chia‐Wei Li(15), Li-Chuan Chan(15), Heng‐Huan Lee(14), Hirohito Yamaguchi(12), Seung-Oe Lim(11), Yongkun Wei(11), Gabriel N. Hortobágyi(10), Jong‐Ho Cha(9), Longfei Huo(9), Yun Wu(8), Lei Nie(8), Sam S. Chang(7), Jun Yao(7), Dihua Yu(6), Linlin Sun(6), Wei-Chao Chang(6), Long‐Yuan Li(6)